GlaxoSmithKline and World Health Organization sign agreement to develop a new treatment for malaria
GlaxoSmithKline and the World Health Organization (WHO) announced that they have signed an agreement for the development of a new treatment for malaria called LAPDAP. LAPDAP, a product that combines